News

French health officials received dozens of reports of syringe pricks at a public festival, sparking fear about HIV and ...
The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...
ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...
The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...
The World Health Organization now recommends lenacapavir, a twice-yearly injectable HIV prevention drug, especially for high-risk groups. This endorse ...
LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...
A breakthrough to reduce risk of HIV in adolescents and adults weighing at least 35 kg. WHO releases the new guidelines ...
USPS changes stamp prices: What to know New Jersey woman nearly dies after taking dangerous amount of popular supplement: ‘I ...
We’ve come a long way in treating HIV, the virus that can lead to AIDs. Just last month, the FDA approved a medication that ...
As expected, the new recommendations that the World Health Organization (WHO) issued for HIV and sexually transmitted ...
Alarice Marsh, M.P.H., a deputy director in the National Department of Health of South Africa and program lead of HIV testing ...
The World Health Organization (WHO) is recommending a twice-yearly injection of lenacapavir for prevention of HIV, according to a press release .